NeuroPace, Inc. (NPCE)
14.28
+0.13
(+0.92%)
USD |
NASDAQ |
Sep 18, 16:00
14.26
-0.02
(-0.11%)
After-Hours: 20:00
NeuroPace Max Drawdown (5Y) : 95.13% for Aug. 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| August 31, 2026 | 95.13% |
| July 31, 2026 | 95.13% |
| June 30, 2026 | 95.13% |
| May 31, 2026 | 95.13% |
| April 30, 2026 | 95.13% |
| March 31, 2026 | 95.13% |
| February 28, 2026 | 95.13% |
| January 31, 2026 | 95.13% |
| Date | Value |
|---|---|
| December 31, 2025 | 95.13% |
| November 30, 2025 | 95.13% |
| October 31, 2025 | 95.13% |
| September 30, 2025 | 95.13% |
| August 31, 2025 | 95.13% |
| July 31, 2025 | 95.13% |
| June 30, 2025 | 95.13% |
| May 31, 2025 | 95.13% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| CVRx, Inc. | 92.82% |
| Accuray, Inc. | 96.17% |
| Micron Solutions, Inc. | 100.0% |
| Orthofix Medical, Inc. | 85.69% |
| ResMed, Inc. | 53.98% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -28.50 |
| Beta (5Y) | 1.943 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 108.6% |
| Historical Sharpe Ratio (5Y) | -0.1002 |
| Historical Sortino (5Y) | -0.268 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 33.34% |